Log In
Print
BCIQ
Print
Print this Print this
 

ALX-0171

  Manage Alerts
Collapse Summary General Information
Company Ablynx N.V.
DescriptionSingle variable domain antibody fragment against viral surface F proteins
Molecular Target RSV F protein
Mechanism of ActionBinds RSV F protein; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsTreat and prevent respiratory syncytial virus (RSV)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today